The US Food and Drug Administration said taking wrong dose of Clonazepam could result in ‘significant sedation, confusion, ...

Clonazepam, an anxiety drug, has been recalled because of a labeling error that could result in harmful consequences.

The drugmaker said that the medication’s strength is mislabeled on the cartons, which could lead to patients taking incorrect ...

"Clonazepam Orally Disintegrating Tablets, USP (C-IV)" on November 18th, due to "potential product carton strength ...

Endo USA has expanded its voluntary recall of clonazepam orally disintegrating tablets due to a mislabeling issue that could lead to patients accidentally ingesting the wrong dosage.

Drug maker Endo, Inc. issued a recall for tablets of clonazepam, the generic for Klonopin. Cartons of the company’s "Orally ...

The company that produces the tablets has said the medication is mislabeled with the incorrect strength on the carton.

Sixteen lots of clonazepam orally disintegrating tablets have been recalled because of a packaging error that could have life ...

Endo, Inc., has expanded its voluntary recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) due to mislabeled ...

The anxiety-reducing drug, Clonazepam, has been recalled after a potentially "life-threatening" label mix-up, the FDA said in the recall.

The agency warned that adults and children who inadvertently took a higher dose of clonazepam than prescribed could ...

The makers of Clonazepam Orally Disintegrating Tablets have issued a voluntary recall over mislabeled product packaging.